Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
WHO Monographs on Selected Medicinal Plants - Volume 1
(1999; 295 pages) Voir le document au format PDF
Table des matières
Afficher le documentAcknowledgements
Afficher le documentIntroduction
Afficher le documentBulbus Allii Cepae
Afficher le documentBulbus Allii Sativi
Afficher le documentAloe
Afficher le documentAloe Vera Gel
Afficher le documentRadix Astragali
Afficher le documentFructus Bruceae
Afficher le documentRadix Bupleuri
Afficher le documentHerba Centellae
Afficher le documentFlos Chamomillae
Afficher le documentCortex Cinnamomi
Afficher le documentRhizoma Coptidis
Afficher le documentRhizoma Curcumae Longae
Afficher le documentRadix Echinaceae
Afficher le documentHerba Echinaceae Purpureae
Afficher le documentHerba Ephedrae
Afficher le documentFolium Ginkgo
Afficher le documentRadix Ginseng
Afficher le documentRadix Glycyrrhizae
Afficher le documentRadix Paeoniae
Afficher le documentSemen Plantaginis
Afficher le documentRadix Platycodi
Afficher le documentRadix Rauwolfiae
Afficher le documentRhizoma Rhei
Afficher le documentFolium Sennae
Afficher le documentFructus Sennae
Afficher le documentHerba Thymi
Afficher le documentRadix Valerianae
Afficher le documentRhizoma Zingiberis
Afficher le documentAnnex. Participants in the WHO Consultation on Selected Medicinal Plants

Semen Plantaginis


Semen Plantaginis is the dried, ripe seed of Plantago afra L., P. indica L., P. ovata Forsk., or P. asiatica L. (Plantaginaceae) (14).


Plantago afra L.

P. psyllium L. (2).

Plantago asiatica


Plantago indica L.

P. arenaria Waldstein et Kitaibel, P. ramosa Asch. (1, 2, 5).

Plantago ovata Forsk.

P. ispaghula Roxb. (4).

Selected vernacular names

Psyllium seed, plantain seed, flea seed, Flohsamen, semences de psyllium (6).

P. afra L.

Flohsamen, Spanish psyllium (6).

P. asiatica

Shazen-shi, Che-qian-zi.

P. indica L.

Flashsamen, fleavort plantago, French psyllium, Spanish psyllium seed, whorled plantago (6).

P. ovata Forsk.

Ashwagolam, aspaghol, aspagol, bazarqutuna, blond psyllium, ch'-ch'ientzu, ghoda, grappicol, Indian plantago, Indische Psylli-samen, isabgol, isabgul, isabgul gola, ispaghula, isphagol, vithai, issufgul, jiru, obeko, psyllium, plantain, spogel seeds (1, 6–9).


Plantago afra L.

An annual, erect, glandular-hairy caulescent herb, with an erect branching stem (0.2–0.4 m in height); it possesses whorls of flattened linear to linear-lanceolate leaves from the upper axils of which flowering stalks as long as the leaves arise. The stalks terminate in ovate-elliptical spikes up to 12mm long. The upper bracts ovate-lanceolate up to 4 mm in length and somewhat similar in character to the lower bracts, but with chloroplastids fewer in the midrib of the proximal portion. The flowers are tetramerous with a calyx of 4 similar persistent, lanceolate sepals, each with green midrib and hyaline lamina, a hypocrateriform corolla of 4 gamopetalous hyaline petals inserted below the ovary, the tube surrounding the ovary and a portion of the filiform, hairy style, the limb with 4-lanceolate, acuminate lobes. The fruit is membranous, 2-celled and 2-seeded (6).

Plantago asiatica L.

Usually wrinkled and contracted leaf and spike, greyish green to dark yellowgreen in colour; when soaked in water and smoothed out, the lamina is ovate or orbicular-ovate, 4–15cm in length, 3–8cm in width; apex acute, and base sharply narrowed; margin slightly wavy, with distinct parallel veins; glabrous or nearly glabrous; petiole is rather longer than the lamina, and its base is slightly expanded with thin-walled leaf-sheath; scape is 10–50cm in length, one-third to one-half of the upper part forming the spike, with dense florets; the lower part of inflorescence often shows pyxidia; roots usually removed, but, if any, fine roots are closely packed (6).

Plantago indica L.

An annual caulescent herb attaining a height of 0.3–0.5m with an erect or diffuse, hairy, frequently branched stem with whorls of linear to filiform leaves, from the axils of the upper ones of which spring peduncles, which are longer than the leaves and more or less umbellate. The lower bracts are transversely obovate below, lanceolate above, with a herbaceous midrib and hyaline margin, glandular hairy; the upper bracts broadly ovate with obtuse summits and also have herbaceous midribs and hyaline margins. The calyx is persistent, hairy, of 2 large spatulate anterior segments and 2 smaller, lateroposterior, lanceolate segments. The corolla is hypocrateriform of 4 petals, the limbs oblong with acute to mucronate summits; the tube of the corolla covering the pyxis and portions of the style. The pyxis is membranous, 2-celled, 2-seeded, and dehisces about or slightly below the middle (6).

Plantago ovata Forsk.

An annual, acaulescent herb, the stem of which is very ramified and bears linear leaves that are lanceolate, dentate, and pubescent. The flowers are white and grouped into cylindrical spikes. The sepals are characterized by a distinct midrib extending from the base to the summit; the petal lobes are oval with a mucronate summit. The seeds are oval and clearly carinate, measure 2–3mm, and are a light grey-pink with a brown line running along their convex side (6, 7).

Plant material of interest: seeds

General appearance

Plantago afra L.

Hemianatropous, silky to the touch; ovate to ovate-elongate, larger at one end than the other; concavo-convex; light to moderate brown, dark brown along the margin, very glossy. Length 1.3–2.7 mm, rarely up to 3mm, and width 0.6– 1.1 mm; the convex dorsal surface somewhat transparent, exhibiting a longitudinal brown area extending nearly the length of the seed and representing the embryo lying beneath the seed coat, and a transverse groove nearer the broader than the narrower end and over the point of union of the hypocotyl and cotyledons; the concave ventral surface with a deep excavation, in the centre of the base of which is an oval yellowish white hilum (1, 6).

Plantago asiatica L.

Flattened ellipsoidal seed, 2–2.25 mm in length, 0.7–1mm in width, 0.3–0.5mm in thickness; externally brown to yellow-brown and lustrous. Under a magnifying glass, the surface of the seed is practically smooth; the dorsal side protrudes like a bow and the ventral side is somewhat dented; micropyle and raphe not observable. A hundred seeds weigh about 0.05 g (3).

Plantago indica L.

Ovate-oblong to elliptical; dark brown to maroon, often dull, rough and reticulate, 1.6–3.0 mm in length and 1.0–1.5 mm in width; concavo-convex, the dorsal surface has a longitudinal light brown area extending lengthwise along the centre and beneath the seed coat and has a median transverse groove, dent, or fissure; the ventral surface with a deep concavity, the edge of which is somewhat flattened and frequently forms a sharp indented angle with the base of the cavity, the latter showing a pale brown to occasionally whitish oval hilum (1, 6).

Plantago ovata Forsk.

Boat-shaped with ovate outline, pinkish grey to brown in colour along the margin with opaque reticulate surface, 2–2.3mm long, 1–1.5mm wide and 1mm thick, usually with central reddish brown oval patch extending about a third of the length of the seed. The convex dorsal surface has a longitudinal brown area extending nearly along the length of the seed that represents the position of the embryo lying beneath the seed-coat, and a transverse groove nearer to the broader than to the narrower extremity and over the points of union of the hypocotyl and cotyledons. The ventral surface shows a deep brown furrow that does not reach to either end of the seeds, in the centre of which is an oval yellowish white hilum, from which extends to the chalazal end a slightly elevated dark brown raphe. The seed is albuminous with oily endosperm; the embryo is straight, formed of two large plano-convex cotyledons and a small radicle in the narrow end and directed towards the micropyle. The seed is mucilaginous and upon soaking in water, the seed-coat swells and the seed becomes enveloped with a colourless mucilage. The weight of 100 seeds is about 0.1 g. A longitudinal cut, perpendicular to the ventral surface and passing through the hilum, shows a thin dark brown testa within which is a narrow endosperm surrounding a large oval lanceolate cotyledon and large pyramidal radicle directed towards the micropyle (1, 4, 6).

Organoleptic properties

Odourless with mucilage-like taste.

Microscopic characteristics

Plantago afra L.

The transverse sections of the seed cut through the central region possess a reniform outline and present for examination a spermoderm, endosperm, and embryo. The spermoderm shows an outer epidermis of mucilaginous epidermal cells with more or less obliterated walls in glycerine mounts; the radial and inner walls swell and disintegrate to form a clear mucilage upon irrigation of the mount with water; and a pigment layer with brown amorphous content. The endosperm composed of irregular-shaped, thick-walled cells with walls of reserve cellulose. The outer layer of this region consists of palisade cells 15–40 µm in height. Aleurone grains and fixed oils are found in the endosperm cells (5).

Plantago asiatica L.

Transverse section reveals a seed-coat consisting of three layers of epidermis composed of cells containing mucilage, a vegetative layer, and a pigment layer of approximately equidiameter cells; in the interior, endosperm thicker than seed-coat, enclosing 2 cotyledons (6).

Plantago indica L.

The transverse section of the seed shows a similar structure to that described above for P. afra, but the palisade cells of the endosperm are up to 52µm in height (6).

P. ovata Forsk.

The transverse cut through the central region possesses a reniform or a concaveconvex outline and shows a testa, an endosperm, and 2 plano-convex cotyledons. Each cotyledon shows aleurone strands. On the convex surface a small raphe. The testa formed of one integument showing outer epidermis consisting of polygonal tabular cells with straight thin anticlinal walls covered with smooth cuticle. They are 52–68µm long, 30–52µm wide and 27–32µm thick. The middle (nutrient) layer is formed of collapsed thin cellulosic parenchyma, usually more than one layer, about 5 or 6 rows. The inner epidermis consists of polygonal cells with straight thin anticlinal walls, containing reddish brown contents; they are 16–38µm long, and 11–20µm wide and 2–3µm thick. The endosperm is formed of irregularly shaped thick cellulosic parenchyma showing an epidermis which is palisade-like, cells containing aleurone grains without inclusion, and fixed oil. The embryo formed of thin-walled cellulosic parenchyma containing fixed oil and aleurone grains. Each cotyledon shows 3 pleurone strands (4).

Powdered plant material

The most commonly used P. ovata powder is greyish brown showing glossy particles, colourless and with mucilage-like taste, characterized by fragments of epidermis formed of thin-walled polygonal cells with smooth cuticle and containing mucilage in the outer tangential and anticlinal walls, staining red with ruthenium red and blue with methylene blue; fragments of the pigment layer which is formed of polygonal cells with thin straight anticlinal walls with brown content traversed by collapsed colourless parenchyma; abundant fragments of endosperm with aleurone grains which are free of content and fixed oil; fragments of embryo tissues showing thin-walled parenchyma containing fixed oil and aleurone grains; few fragments showing spiral vessels attaining 11– 15µm width and few fibres which are elongated with thin pitted walls and pointed ends attaining 80–180µm in length and 8–12µm in width (4).

Geographical distribution

P. afra and P. indica, west Mediterranean countries (6); P. asiatica, Japan (3). P. ovata, Asia and the Mediterranean countries; the plant is cultivated extensively in India and Pakistan and adapts to western Europe and subtropical regions (4, 6, 8–10).

General identity tests

Macroscopic and microscopic examination (1–4); determining the swelling index (1–4); and test for reducing sugars (3, 4).

Purity tests


The test for Salmonella spp. in Semen Plantaginis products should be negative. The maximum acceptable limits of other microorganisms are as follows (11– 13). Preparations for internal use: aerobic bacteria-not more than 105/g; fungi-not more than 104/g; enterobacteria and certain Gram-negative bacteria -not more than 103/g; Escherichia coli-0/g.


Swelling index of P. afra and P. ovata, not less than 10 (2); of P. indica, not less than 8 (1); of P. asiatica, to be established in accordance with national requirements.

Foreign organic matter

Not more than 0.5% (1).

Total ash

Not more than 4.0% (1).

Acid-insoluble ash

Not more than 1.0% (1).


Not more than 14% (2).

Pesticide residues

To be established in accordance with national requirements. Normally, the maximum residue limit of aldrin and dieldrin in Semen Plantaginis is not more than 0.05 mg/kg (2). For other pesticides, see WHO guidelines on quality control methods for medicinal plants (11) and guidelines for predicting dietary intake of pesticide residues (13).

Heavy metals

Recommended lead and cadmium levels are not more than 10 and 0.3mg/kg, respectively, in the final dosage form of the plant material (11).

Radioactive residues

For analysis of strontium-90, iodine-131, caesium-134, caesium-137, and plutonium-239, see WHO guidelines on quality control methods for medicinal plants (11).

Other purity tests

Tests for water-soluble extractive to be established in accordance with national requirements.

Chemical assays

Mucilage (10–30%) (14). Plantago products can be assayed for their fibre content by the method described by the Association of Official Analytical Chemists (14).

Major chemical constituents

Plantago seeds contain 10–30% mucilaginous hydrocolloid, which is localized in the outer seed-coat (husk) and is the major, active principle. The mucilage is composed of a soluble polysaccharide fraction containing mainly arabinoxylans (85%). The polymer backbone is a xylan with 1 → 3 and 1 → 4 linkages, with no apparent regularity in their distribution. The monosaccharides in this main chain are substituted on C-2 or C-3 by L-arabinose, D-xylose, and α-Dgalacturonyl-(1 → 2)-L-rhamnose. In addition, secondary metabolites in the seed include sterols, triterpenes, and aucubin glycosides (4–7, 15).

Dosage forms

Seeds, powder, and granules. Store in well-closed containers, in a cool dry place, protected from light (1–4).

Medicinal uses

Uses supported by clinical data

As a bulk-forming laxative used to restore and maintain regularity (2, 4, 16–20). Semen Plantaginis is indicated in the treatment of chronic constipation, temporary constipation due to illness or pregnancy, irritable bowel syndrome, constipation related to duodenal ulcer or diverticulitis (17–22). It is also used to soften the stools of those with haemorrhoids, or after anorectal surgery (16, 17).

Uses described in pharmacopoeias and in traditional systems of medicine

While Semen Plantaginis is primarily used in the treatment of constipation, it has also been used effectively in the short-term symptomatic treatment of diarrhoea of various etiologies (23, 24).

Uses described in folk medicine, not supported by experimental or clinical data

Other medical uses claimed for Semen Plantaginis include use as an expectorant and antitussive, an antibacterial agent, and a diuretic and in the treatment of rheumatic and gouty afflictions, glandular swelling, and bronchitis (8).


Clinical pharmacology


Semen Plantaginis increases the volume of the faeces by absorbing water in the gastrointestinal tract, which stimulates peristalsis (25, 26). The intraluminal pressure is decreased, colon transit is increased, and the frequency of defecation is increased (15, 16, 25).

When mixed with water, the therapeutic efficacy of the drug is due to the swelling of the mucilaginous seed coat which gives bulk and lubrication (7). Semen Plantaginis increases stool weight and water content owing to the water-bound fibre residue and an increased faecal bacterial mass. Clinical studies have demonstrated that ingestion of 18 g of Semen Plantaginis significantly increases faecal fresh and dry weights as compared with weights obtained with placebo (15).

Antidiarrhoeal activity

The antidiarrhoeal effects of Semen Plantaginis have been extensively investigated in patients with acute and chronic diarrhoea (23, 24). An increase in the viscosity of the intestinal contents due to the binding of fluid and an increased colonic transit time (decreased frequency of defecation) were observed in patients treated with the drug (23, 24).


Known hypersensitivity or allergy to the plant; faecal impaction or intestinal obstruction; diabetes mellitus where insulin adjustment is difficult (27).


Semen Plantaginis products should always be taken with sufficient amounts of liquid, and at least half an hour after other medications to prevent delayed absorption of the latter. If bleeding or no response occurs after ingesting the drug, or if abdominal pain occurs 48 hours after treatment, treatment should be stopped and medical advice sought. If diarrhoea persists longer than 3 or 4 days, medical attention should be sought (28).

To prevent the generation of airborne dust, users should spoon the product from the container directly into a drinking glass and then add liquid (28). To minimize the potential for allergic reaction, health professionals who frequently dispense powdered Semen Plantaginis should avoid inhaling airborne dust while handling these products.



Semen Plantaginis should be taken with adequate volumes of fluid. It should never be taken orally as the dried powder, because of the possibility of bowel obstruction. In patients who are confined to bed or do little physical exercise, a medical examination may be necessary prior to treatment with the drug.

Drug interactions

Bulking agents have been reported to diminish the absorption of some minerals (calcium, magnesium, copper, and zinc), vitamin B12, cardiac glycosides, and coumarin derivatives (2931). The co-administration of Semen Plantaginis with lithium salts has been reported to reduce the plasma concentrations of the lithium salts and may inhibit their absorption from the gastrointestinal tract (32). Semen Plantaginis has also been reported to decrease both the rate and extent of carbamazepine absorption, inducing subclinical levels of the drug (33). Therefore, ingestion of lithium salts or carbamazepine and Semen Plantaginis should be separated in time as far as possible (33). Individual monitoring of the plasma levels of the drug in patients taking Semen Plantaginis products is also recommended. Insulin-dependent diabetic people may require less insulin (27).

Other precautions

No information available concerning carcinogenesis, mutagenesis, impairment of fertility; drug and laboratory test interactions; nursing mothers, paediatric use, or teratogenic or non-teratogenic effects on pregnancy.

Adverse reactions

Sudden increases in dietary fibre may cause temporary gas and bloating. These side-effects may be reduced by gradually increasing fibre intake, starting at one dose per day and gradually increasing to three doses per day (28). Occasional flatulence and bloating may be reduced by decreasing the amount of Semen Plantaginis taken for a few days (28).

Allergic reactions to Plantago products in response to ingestion or inhalation have been reported, especially after previous occupational exposure to these products (34–36). These reactions range from urticarial rashes to anaphylactic reactions (rare). One case of fatal bronchospasm has been reported in a Plantagosensitive patient with asthma (34).


The suggested average dose is 7.5 g dissolved in 240 ml water or juice taken orally 1–3 times daily depending on the individual response. The recommended dose for children aged 6–12 years is one-half the adult dose. For children under 6 years, a physician should be consulted. An additional glass of liquid is recommended after ingestion of the drug and generally provides an optimal response. Continued use for 2 or 3 days is needed for maximum laxative benefit.


1. The United States pharmacopeia XXIII. Rockville, MD, US Pharmacopeial Convention, 1995.

2. European pharmacopoeia, 3rd ed. Strasbourg, Council of Europe, 1997.

3. The pharmacopoeia of Japan XIII. Tokyo, The Society of Japanese Pharmacopoeia, 1996.

4. African pharmacopoeia, 1st ed. Lagos, Organization of African Unity, Scientific, Technical & Research Commission, 1985.

5. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. Paris, Lavoisier, 1995.

6. Youngken HW. Textbook of pharmacognosy, 6th ed. Philadelphia, Blakiston, 1950.

7. Tyler VE, Brady LR, Robbers JE, eds. Pharmacognosy, 9th ed. Philadelphia, Lea & Febiger, 1988:52–53.

8. Kapoor LD. Handbook of Ayurvedic medicinal plants. Boca Raton, FL, CRC Press, 1990:267.

9. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, August 8, 1995 production (an on-line database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network (STN) of Chemical Abstracts Services).

10. Mossa JS, Al-Yahya MA, Al-Meshal IA. Medicinal plants of Saudi Arabia, Vol. 1. Riyadh, Saudi Arabia, King Saud University Libraries, 1987:262–265.

11. Quality control methods for medicinal plant materials. Geneva, World Health Organization, 1998.

12. Deutsches Arzneibuch 1996. Vol. 2. Methoden der Biologie. Stuttgart, Deutscher Apotheker Verlag, 1996.

13. Guidelines for predicting dietary intake of pesticide residues, 2nd rev. ed. Geneva, World Health Organization, 1997 (unpublished document WHO/FSF/FOS/97.7; available from Food Safety, WHO, 1211 Geneva 27, Switzerland).

14. Prosky L et al. Determination of total dietary fiber in food and food products: collaborative study. Journal of the Association of Official Analytical Chemists, 1985, 68:677–679.

15. Marteau P et al. Digestibility and bulking effect of ispaghula husks in healthy humans. Gut, 1994, 35:1747–1752.

16. Sölter H, Lorenz D. Summary of clinical results with Prodiem Plain, a bowel regulating agent. Today's therapeutic trends, 1983, 1:45–59.

17. Marlett JA et al. Comparative laxation of psyllium with and without senna in an ambulatory constipated population. American journal of gastroenterology, 1987, 82:333– 337.

18. Lennard-Jones JE. Clinical management of constipation. Pharmacology, 1993, 47:216– 223.

19. Reynolds JEF, ed. Martindale, the extra pharmacopoeia, 30th ed. London, Pharmaceutical Press, 1993.

20. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York, Pergamon Press, 1996.

21. Edwards C. Diverticular disease of the colon. European journal of gastroenterology and hepatology, 1993, 5:583–586.

22. Ligny G. Therapie des Colon irritabile; Kontrollierte Doppelblindstudie zur Prüfung der Wirksamkeit einer hemizellulosehaltigen Arzneizubereitung. Therapeutikon, 1988, 7:449–453.

23. Qvitzau S, Matzen P, Madsen P. Treatment of chronic diarrhea: loperamide versus ispaghula husk and calcium. Scandinavian journal of gastroenterology, 1988, 23:1237– 1240.

24. Harmouz W. Therapy of acute and chronic diarrhea with Agiocur ®. Medizinische Klinik, 1984, 79:32–33.

25. Read NW. Dietary fiber and bowel transit. In: Vahouny GV, Kritchevsky D, eds. Dietary fiber. Basic and clinical aspects. New York, Plenum Press, 1986.

26. Stevens J et al. Comparison of the effects of psyllium and wheat bran on gastrointestinal transit time and stool characteristics. Journal of the American Dietetic Association, 1988, 88:323–326.

27. Bradley PR, ed. British herbal compendium, Vol. 1. Bournemouth, British Herbal Medicine Association, 1983:199–203.

28. Physicians' desk reference, 45th ed. Montvale, NJ, Medical Economics Company, 1991:1740–1741.

29. Gattuso JM, Kamm MA. Adverse effects of drugs used in the management of constipation and diarrhea. Drug safety, 1994, 10:47–65.

30. Hänsel R et al., eds. Hagers Handbuch der Pharmazeutischen Praxis, Vol. 6, 5th ed. Berlin, Springer-Verlag, 1994.

31. Drews L, Kies C, Fox HM. Effect of dietary fiber on copper, zinc, and magnesium utilization by adolescent boys. American journal of clinical nutrition, 1981, 32:1893– 1897.

32. Pearlman BB. Interaction between lithium salts and ispaghula husks. Lancet, 1990, 335:416.

33. Etman MA. Effect of a bulk forming laxative on the bioavailability of carbamazepine in man. Drug development and industrial pharmacy, 1995, 21:1901–1906.

34. Hubert DC et al. Fatal bronchospasm after oral ingestion of ispaghula. Postgraduate medical journal, 1995, 71:305–306.

35. Freeman GL. Psyllium hypersensitivity. Annals of allergy, 1994, 73:490–492.

36. Knutson TW et al. Intestinal reactivity in allergic and nonallergic patients; an approach to determine the complexity of the mucosal reaction. Journal of allergy and clinical immunology, 1993, 91:553–559.


vers la section précédente
vers la section suivante
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 15 décembre 2016